Advancements in Colorectal Cancer Research
David Fenstermacher, PhD, provides insights regarding key advancements and pipeline treatments for metastatic colorectal cancer.
mCRC Treatment Sequencing Influenced By Combination Therapy
The panelists examine a recent FDA approval that provides new opportunities for effective combination strategies in mCRC treatment.
Improving Patient Adherence in Diabetic Macular Edema Eye Care
Joseph M. Coney, MD, FACS, reviews best practices for improving adherence to treatment among patients with diabetic macular edema through comprehensive education on the disease and available therapies.
Expert Forecasts in the Perioperative Landscape for NSCLC Patients
Experts discuss changes they foresee in the perioperative approach landscape for patients with NSCLC.
Enhancing NSCLC Neoadjuvant Therapy
A panel deliberates post-neoadjuvant strategies and data requirements for optimizing immune checkpoint inhibitors in NSCLC neoadjuvant therapy.
Keeping Abreast of Progress in the Management of mNSCLC
Panelists share their final thoughts on staying updated with the latest advancements in the field.
Accelerated Diagnostic Testing for the Detection of mNSCLC
Experts emphasize the crucial role of swift diagnostic testing, especially through liquid biopsies.
Best Practices and Considerations for Monitoring Treatment Responses in mNSCLC
Specialists delve into strategies for monitoring treatment response and the importance of assessing symptoms during the initial three treatment cycles.
Management Insights for Patients With Hemophilia
Russell P. Gollard, MD, FACP, discusses hemophilia patients in their plan, identifying these patients, and treatment with newer monoclonal factor products.
Socioeconomic Factors Impacting Development of Cardiac Disease
Financial and geographic disparities contributing to elevated risk for heart disease are explored.
Identifying Key Risk Factors for Heart Failure
Robert Groves, MD, leads a panel discussion surrounding risk factors related to heart disease.
Transitioning to Biosimilars: Considerations for Providers and Payers
Panelists explore opportunities for biosimilars to manage inflammatory conditions.
Utilizing Recently Approved Biosimilars in Clinical Practice
Experts explore current and future use of biosimilars in dermatology, gastroenterology, and rheumatology.
Clinical Pathways and Streamlined Decision-Making in HCC Management
Benefits of clinical pathway implementation in HCC management are examined.
Identifying and Navigating Challenges Associated With Clinical Pathways in the Treatment of HCC
Ryan Haumschild, PharmD, MS, MBA, drives an expert discussion focused on challenges associated with clinical pathway utilization in treating patients with HCC.
First-, and Second-, and Third-Line Agents in mCRC
Medical experts discuss treatment-related toxicity management strategies in mCRC.
Implementing Targeted Therapies Into mCRC Treatment Algorithm
Ben George, MD, and John L. Marshall, MD, analyze the use of targeted therapies as an alternative to chemotherapy in mCRC treatment.
Navigating DLBCL Treatment Strategies for Patients Experiencing Resistance to Therapy
In his closing thoughts, Dr Gordon discusses navigation of treatment resistance in DLBCL management.
Additional Treatment Strategies and Collaborative Care for Patients with DLBCL
The impact of collaborative care in DLBCL treatment is explored by a medical expert.
Challenges in Diabetes Therapy Adherence: Impact on Early Intervention and Long-Term Visual Outcomes
Joseph M. Coney, MD, FACS, discusses the challenges physicians encounter when treating diabetic macular edema and the impact of the disease on patients’ quality of life.
Chemoimmunotherapy Timing: Pre or Post Surgery for Patients With NSCLC
Experts deliberate on the optimal timing of chemoimmunotherapy and if it should be before or after surgery.
Neoadjuvant Therapy in Early NSCLC Treatment
A panel discusses the role of neoadjuvant therapy in the current treatment approach for early stages of NSCLC.
Supportive Care, Decision-Making, and Fatigue Management
Providers speak to the importance of encouraging patients to self-report adverse reactions and participate in shared decision making.
Addressing the Impact of Platinum Shortages in mNSCLC Treatment
Experts address the impact of platinum shortages, 4-cycle platinum chemotherapy, and available treatments beyond platinum chemotherapy.
Key Considerations for Future CKD Treatment Approach
Expert panelists share final points of emphasis regarding treatment for CKD.
Early CKD Intervention Limiting Down-The-Line Costs Associated With ESRD Care
Medical experts highlight the financial benefit of early CKD intervention.
Unmet Needs in Current CKD Treatment Landscape
Barriers inhibiting optimal CKD treatment for patients are underlined.
The Impact of Clinical Pathways on Healthcare Resource Allocation in HCC Management
Ghassan Abou-Alfa, MD, MBA, and Mohamed Salem, MD, provide insights regarding potential clinical pathway-driven challenges associated with HCC management.
Evaluating Clinical Pathway Implementation in HCC Treatment
A panel of medical experts open a discussion surrounding key treatment strategies in management of hepatocellular carcinoma (HCC).
Targetable Mutations Investigated Or Utilized in mCRC
Medical experts explore the main treatment goals and modalities beyond pharmacotherapies for mCRC treatment, and discuss targetable mutations being explored in mCRC.
